pravastatin has been researched along with Fractures, Bone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, CP; Reid, IR; Tonkin, A | 1 |
| Jadhav, SB; Jain, GK | 1 |
| Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Rini, GB; Rizzo, M | 1 |
| El-Sohemy, A | 1 |
| Baker, J; Emberson, J; Hague, W; Hunt, D; MacMahon, S; Reid, IR; Sharpe, N; Tonkin, A | 1 |
2 review(s) available for pravastatin and Fractures, Bone
| Article | Year |
|---|---|
Statins and osteoporosis: new role for old drugs.
Topics: Animals; Atorvastatin; Bone and Bones; Clinical Trials as Topic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Lovastatin; Osteogenesis; Osteoporosis; Pharmacokinetics; Pravastatin; Pyridines; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
Statins, fracture risk, and bone remodeling: What is true?
Topics: Bone Remodeling; Female; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Myocardial Ischemia; Osteoporosis; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin | 2006 |
1 trial(s) available for pravastatin and Fractures, Bone
| Article | Year |
|---|---|
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
Topics: Aged; Anticholesteremic Agents; Bone and Bones; Cohort Studies; Coronary Disease; Double-Blind Method; Female; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteoporosis; Pravastatin | 2001 |
3 other study(ies) available for pravastatin and Fractures, Bone
| Article | Year |
|---|---|
Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial.
Topics: Atorvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic | 2005 |
Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Topics: Adolescent; Adult; Aged; Bone and Bones; Case-Control Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Female; Forearm Injuries; Fractures, Bone; Hip Fractures; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Odds Ratio; Pravastatin; Registries; Risk Factors; Spinal Fractures | 2006 |
Statin drugs and the risk of fracture.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cholestyramine Resin; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pravastatin; Risk; Transforming Growth Factor beta | 2000 |